HALOBETASOL\TAZAROTENE: 77 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
77
Total FAERS Reports
0
Deaths Reported
2
Hospitalizations
77
As Primary/Secondary Suspect
Active Ingredient: HALOBETASOL PROPIONATE\TAZAROTENE ·
First Report: 2019 · Latest Report: 20250101
What Are the Most Common HALOBETASOL\TAZAROTENE Side Effects?
#1 Most Reported
Drug ineffective
11 reports (14.3%)
#2 Most Reported
Skin burning sensation
10 reports (13.0%)
#3 Most Reported
Application site pain
10 reports (13.0%)
All HALOBETASOL\TAZAROTENE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 11 | 14.3% | 0 | 0 |
| Application site pain | 10 | 13.0% | 0 | 0 |
| Skin burning sensation | 10 | 13.0% | 0 | 1 |
| Psoriasis | 9 | 11.7% | 0 | 0 |
| Application site irritation | 8 | 10.4% | 0 | 0 |
| Application site erythema | 7 | 9.1% | 0 | 0 |
| Pruritus | 7 | 9.1% | 0 | 1 |
| Skin exfoliation | 7 | 9.1% | 0 | 1 |
| Erythema | 6 | 7.8% | 0 | 1 |
| Rash | 6 | 7.8% | 0 | 0 |
| Skin irritation | 5 | 6.5% | 0 | 0 |
Who Reports HALOBETASOL\TAZAROTENE Side Effects? Age & Gender Data
Gender: 64.2% female, 35.8% male. Average age: 52.4 years. Most reports from: US. View detailed demographics →
Is HALOBETASOL\TAZAROTENE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 12 | 0 | 0 |
| 2020 | 9 | 0 | 0 |
| 2021 | 10 | 0 | 1 |
| 2023 | 1 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is HALOBETASOL\TAZAROTENE Used For?
| Indication | Reports |
|---|---|
| Psoriasis | 39 |
| Product used for unknown indication | 25 |
Official FDA Label for HALOBETASOL\TAZAROTENE
Official prescribing information from the FDA-approved drug label.